References
1. Nishi Н., Miyamoto S., Takanashi S., Minamimura H., Ishikawa H., Shimizu Y. Complete revascularization in patients with severe left ventricular dysfunction. Ann Thorac Cardiovasc Surg. 2003; 9 (2): 111–6.
2. Lozonschi L., Kohmoto T., Osaki S., De Oliveira S., Dhingra S., Akhter S., et al. Coronary bypass in left ventricular dysfunction and differential cardiac recovery. Asian Cardiovasc Thorac Ann. 2017; 25 (9): 586–93. DOI: https://doi.org/10.1177/0218492317744472
3. Farkouh M., Domanski M., Dangas G.; FREEDOM Follow-On Study Investigators. Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study. J Am Coll Cardiol. 2019; 73 (6): 629–38.
4. Nagendran J., Norris C., Graham M., Ross D., Macarthur R., Kieser T., et al. Coronary revascularization for patients with severe left ventricular dysfunction. Randomized Controlled Trial. Ann Thorac Surg. 2013; 96 (6): 2038–44. DOI: https://doi.org/10.1016/j.athoracsur.2013.06.052
5. Bangalore S., Guo Y., Samadashvili Z., Blecker S., Hannan E. Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction. Circulation. 2016; 133: 2132–40. DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.021168
6. Sousa-Uva M., Neumann F., Ahlsson A., Alfonso F., Banning A., Benedetto U. ESC/EACTS guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2019; 55 (1): 4–90. DOI: https://doi.org/10.1093/ejcts/ezy289
7. Kunadia V., Zaman A., Qiu W. Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies. Eur J Heart Fail. 2011; 13 (7): 773–84. DOI: https://doi.org/10.1093/eurjhf/hfr037
8. Allen B.S. Myocardial protection: a forgotten modality. Eur J Cardiothorac Surg. 2020; 57 (2): 263–70. DOI: https://doi.org/10.1093/ejcts/ezz215
9. Elvenes O.P., Korvald C., Myklebust R. Warm retrograde blood cardioplegia saves more ischemic myocardium but may cause a functional impairment compared to cold crystalloid. Eur J Cardiothorac Surg. 2002; 22: 402–9.
10. De Bruyn H., Gelders F., Gregoir T., Waelbers V., Starinieri P., et al. Myocardial protection during cardiac surgery: warm blood versus crystalloid cardioplegia. World J Cardiovasc Dis. 2014; 4: 422–31. DOI: https://doi.org/10.4236/wjcd.2014.49053
11. Nardi Р., Pisano С., Bertoldo F., Vacirca S., Saitto G., Costantino A., et al. Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery. Cell Death Discov. 2018; 4: 23. DOI: https://doi.org/10.1038/s41420-018-0031-z
12. Calafiore A., Teodori G., Mezzetti A., Bosco G., Verna A., Di Giammarco G. Intermittent antegrade warm blood cardioplegia. Ann Cardiothorac Surg. 1995; 59: 398–402.
13. Ad N., Holmes S., Massimiano P., Rongione A., Fornaresio L., Fitzgerald D. The use of del Nido cardioplegia in adult cardiac surgery: a prospective randomized trial. J Thorac Cardiovasc Surg. 2018; 155 (3): 1011–8. DOI: https://doi.org/10.1016/j.jtcvs.2017.09.146
14. Buckberg G. Myocardial temperature management during aortic clamping for cardiac surgery. Protection, preoccupation, and perspective. J Thorac Cardiovasc Surg. 1991; 102: 895– 903.
15. Koechlin L., Rrahmani B., Gahl B., Berdajs D., Eckstein F., Reuthebuch O. Microplegia versus cardioplexol in coronary artery bypass surgery with minimal extracorporeal circulation: comparison of two cardioplegia concepts. Thorac Cardiovasc Surg. 2020; 68 (3): 223–31. DOI: https://doi.org/10.1055/s-0039-1687843
16. Zeriouh M., Heider A., Rahmanian P., Choi Y., Sabashnikov A., Scherner M., et al. Six-years survival and predictors of mortality after CABG using cold vs. warm blood cardioplegia in elective and emergent settings. J Cardiothorac Surg. 2015; 10: 180. DOI: https://doi.org/10.1186/s13019-015-0384-9
17. Kuhn E., Liakopoulos O., Slottosch Y., Deppe A., Choi Y.-H., Madershahian N., et al. Buckberg versus calafiore cardioplegia in patients with acute coronary syndromes. Thorac Cardio-vasc Surg. 2018; 66 (6): 457–63. DOI: https://doi.org/10.1055/s-0037-1612604
18. Bazylev V.V., Evdokimov M.E., Pantyuhina M. A. Variant of blood, warm, low-volume, single-dose cardioplegia for adult myocardial revascularization. Clinical and Experimental Surgery. Petrovsky Journal. 2021; 9 (2): 68–75. DOI: https://doi.org/10.33029/2308-1198-2021-9-2-68-75 (in Russian)
19. Caputo М., Santo К., Angelini G., et al. Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial. Eur J Cardiothorac Surg. 2011; 40: 722–9. DOI: https://doi.org/10.1016/j.ejcts.2010.09.049
20. Caputo M., Bryan A., Calafiore A., Suleiman M., Angelini G. Intermittent antegrade hyperkalaemic warm blood cardioplegia supplemented with magnesium prevents myocardial substrate derangement in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 1998; 14 (6): 596–601. DOI: https://doi.org/10.1016/s1010-7940(98)00247-4
21. Dobson G., Jones M. Adenosine and lidocaine: a new concept in non-depolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg. 2004; 127: 794–805. DOI: https://doi.org/10.1016/S0022-5223(03)01192-9
22. Corvera J., Kin H., Dobson G., Karendi F., Halkos M., Katzmark S., et al. Polarized arrest with warm or cold adenosine-lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg. 2005; 129: 599–606.
23. Canyon S., Dobson G. Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat. Am J Physiol. 2004; 287: 86–95. DOI: https://doi.org/10.1152/ajpheart.00273.2004
24. Guru V., Omura J., Alghamdi A., Weisel R., Fremes S. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation 2006; 114 (1): I331–8. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.001644
25. Fan Y., Zhang A., Xiao Y., Weng Y., Hetzer R. Warm versus cold cardioplegia for heart surgery: a meta-analysis. Eur J Cardiothorac Surg. 2020; 37 (4): 912–9. DOI: https://doi.org/10.1016/j.ejcts.2009.09.030
26. Domanski M., Mahaffey K., Hasselblad V., Brener S., Smith P., Hillis G. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA. 2011; 305: 585–91. DOI: https://doi.org/10.1001/jama.2011.99
27. Brat R., Tosovsky J., Januska J. Myocardial function in early hours after coronary artery bypass grafting in patients with left ventricular dysfunction: comparison of blood and crystalloid cardioplegia. J Cardiovasc Surg. 2004; 45 (3): 265–9.
28. De Jonge M., Van Boxtel A., Mokhles M, Bramer S. Intermittent warm blood versus cold crystalloid cardioplegia for myocardial protection: a propensity score-matched analysis of 12-year single-center experience. Perfusion. 2015; 30: 243–9. DOI: https://doi.org/10.1177/0267659114540023